Last Updated on September 21, 2023 by The Health Master
In a significant stride towards a universal influenza vaccine, the U.S. National Institutes of Health (NIH) has kicked off an early-stage Human trial of their groundbreaking experimental vaccine, FluMos-v2.
This vaccine aims to combat six strains of the influenza virus, offering a new level of protection against both influenza A and B viruses.
The Quest for an Ideal Universal Influenza Vaccine
The NIH’s ambitious venture into developing a universal influenza vaccine is fueled by the aspiration to reduce the frequency of vaccinations and broaden the spectrum of protection against diverse strains of the influenza virus.
Hugh Auchincloss, the NIAID’s acting director, said, “With each new universal influenza vaccine candidate and clinical trial, we take another step toward that goal.”
FluMos-v2: A Breakthrough Vaccine Candidate
FluMos-v2 is meticulously crafted to target four strains of influenza A virus and two strains of influenza B virus.
This promising vaccine, developed by the proficient researchers at NIAID’s Vaccine Research Center, holds the potential to revolutionize influenza prevention.
Enrolling the Pioneers
The early-stage human trial is set to enlist 24 healthy volunteers, carefully selected between the ages of 18 and 50.
These pioneers will receive two intramuscular injections of FluMos-v2 at a 16-week interval, allowing researchers to observe and analyze the vaccine’s efficacy and safety profile.
Moderna’s Strides in Flu Vaccine Development
In a parallel development, COVID vaccine manufacturer Moderna announced a breakthrough in their flu vaccine research.
Their vaccine demonstrated a notably heightened immune response against all four A and B strains of the influenza virus in a late-stage trial, surpassing the effectiveness of conventional flu shots.
Coupled with Moderna’s encouraging advancements, the landscape of influenza prevention is poised for a transformative shift.
These endeavors signify a significant stride towards a future where protection against influenza is more potent and accessible than ever before.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: